U.S. markets close in 2 hours 8 minutes
  • S&P 500

    4,229.15
    +27.53 (+0.66%)
     
  • Dow 30

    34,725.21
    +176.68 (+0.51%)
     
  • Nasdaq

    13,745.16
    +112.32 (+0.82%)
     
  • Russell 2000

    2,268.08
    +26.66 (+1.19%)
     
  • Crude Oil

    64.91
    +0.20 (+0.31%)
     
  • Gold

    1,830.80
    +15.10 (+0.83%)
     
  • Silver

    27.51
    +0.03 (+0.12%)
     
  • EUR/USD

    1.2165
    +0.0097 (+0.80%)
     
  • 10-Yr Bond

    1.5790
    +0.0180 (+1.15%)
     
  • GBP/USD

    1.3995
    +0.0103 (+0.74%)
     
  • USD/JPY

    108.6450
    -0.4400 (-0.40%)
     
  • BTC-USD

    58,117.41
    +1,167.42 (+2.05%)
     
  • CMC Crypto 200

    1,503.61
    +67.82 (+4.72%)
     
  • FTSE 100

    7,129.71
    +53.54 (+0.76%)
     
  • Nikkei 225

    29,357.82
    +26.45 (+0.09%)
     

We Think Mednow (CVE:MNOW) Can Afford To Drive Business Growth

  • Oops!
    Something went wrong.
    Please try again later.
Simply Wall St
·4 min read
  • Oops!
    Something went wrong.
    Please try again later.

Just because a business does not make any money, does not mean that the stock will go down. For example, although Amazon.com made losses for many years after listing, if you had bought and held the shares since 1999, you would have made a fortune. But while history lauds those rare successes, those that fail are often forgotten; who remembers Pets.com?

So, the natural question for Mednow (CVE:MNOW) shareholders is whether they should be concerned by its rate of cash burn. For the purpose of this article, we'll define cash burn as the amount of cash the company is spending each year to fund its growth (also called its negative free cash flow). We'll start by comparing its cash burn with its cash reserves in order to calculate its cash runway.

Check out our latest analysis for Mednow

How Long Is Mednow's Cash Runway?

A cash runway is defined as the length of time it would take a company to run out of money if it kept spending at its current rate of cash burn. In October 2020, Mednow had CA$3.3m in cash, and was debt-free. Looking at the last year, the company burnt through CA$1.2m. So it had a cash runway of about 2.7 years from October 2020. That's decent, giving the company a couple years to develop its business. The image below shows how its cash balance has been changing over the last few years.

debt-equity-history-analysis
debt-equity-history-analysis

How Is Mednow's Cash Burn Changing Over Time?

In our view, Mednow doesn't yet produce significant amounts of operating revenue, since it reported just CA$41k in the last twelve months. As a result, we think it's a bit early to focus on the revenue growth, so we'll limit ourselves to looking at how the cash burn is changing over time. Its cash burn positively exploded in the last year, up 431%. Given that sharp increase in spending, the company's cash runway will shrink rapidly as it depletes its cash reserves. Mednow makes us a little nervous due to its lack of substantial operating revenue. So we'd generally prefer stocks from this list of stocks that have analysts forecasting growth.

How Hard Would It Be For Mednow To Raise More Cash For Growth?

Given its cash burn trajectory, Mednow shareholders may wish to consider how easily it could raise more cash, despite its solid cash runway. Issuing new shares, or taking on debt, are the most common ways for a listed company to raise more money for its business. Commonly, a business will sell new shares in itself to raise cash and drive growth. By looking at a company's cash burn relative to its market capitalisation, we gain insight on how much shareholders would be diluted if the company needed to raise enough cash to cover another year's cash burn.

Mednow's cash burn of CA$1.2m is about 1.6% of its CA$77m market capitalisation. So it could almost certainly just borrow a little to fund another year's growth, or else easily raise the cash by issuing a few shares.

Is Mednow's Cash Burn A Worry?

As you can probably tell by now, we're not too worried about Mednow's cash burn. For example, we think its cash burn relative to its market cap suggests that the company is on a good path. Although we do find its increasing cash burn to be a bit of a negative, once we consider the other metrics mentioned in this article together, the overall picture is one we are comfortable with. Considering all the factors discussed in this article, we're not overly concerned about the company's cash burn, although we do think shareholders should keep an eye on how it develops. Separately, we looked at different risks affecting the company and spotted 3 warning signs for Mednow (of which 2 are a bit concerning!) you should know about.

If you would prefer to check out another company with better fundamentals, then do not miss this free list of interesting companies, that have HIGH return on equity and low debt or this list of stocks which are all forecast to grow.

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.